购物车
- 全部删除
- 您的购物车当前为空
L-Thyroxine sodium salt pentahydrate (Sodium levothyroxine pentahydrate) 是一种甲状腺激素,具有抗胆固醇活性,抑制甲状腺癌结节释放甲状腺激素,用于甲状腺功能减退症、肌性水肿、克汀病和肥胖症等免疫与内分泌疾病。
L-Thyroxine sodium salt pentahydrate (Sodium levothyroxine pentahydrate) 是一种甲状腺激素,具有抗胆固醇活性,抑制甲状腺癌结节释放甲状腺激素,用于甲状腺功能减退症、肌性水肿、克汀病和肥胖症等免疫与内分泌疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 mg | ¥ 150 | 期货 | |
100 mg | ¥ 225 | 期货 | |
500 mg | ¥ 540 | 期货 | |
1 mL x 10 mM (in DMSO) | ¥ 595 | 期货 |
产品描述 | L-Thyroxine sodium salt pentahydrate (Sodium levothyroxine pentahydrate) is a thyroid hormone with anticholesterol activity that inhibits the release of thyroid hormones from thyroid cancer nodules and is used in immune and endocrine disorders such as hypothyroidism, myxedema, cretinism and obesity. diseases, such as hypothyroidism, myxedema, cretinism and obesity. |
体内活性 | 在喂养12周无碘饮食的实验大鼠中,与标准饮食的对照组相比,三碘甲状腺原氨酸和L-甲状腺素的水平显著下降。在低剂量 L-Thyroxine sodium salt pentahydrate 治疗组中,观察到L-甲状腺素水平的增加,而三碘甲状腺原氨酸水平与对照组几乎无差异。接受高剂量 L-Thyroxine sodium salt pentahydrate 治疗的大鼠相比未治疗的甲状腺功能减退组,其三碘甲状腺原氨酸和L-甲状腺素的循环浓度显著增加,与对照组相比,L-甲状腺素水平显著增加。[2] |
别名 | 左旋甲状腺素钠五水合物, Sodium levothyroxine pentahydrate |
分子量 | 888.93 |
分子式 | C15H20I4NNaO9 |
CAS No. | 6106-07-6 |
密度 | 2.381 g/cm3 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | H2O: < 0.1 mg/mL (insoluble) DMSO: 20 mg/mL (22.5 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
评论内容